MARKET

BIOQ

BIOQ

Bioqual
OTCPK
77.00
NaN%
Closed 09:30 04/23 EDT
OPEN
--
PREV CLOSE
77.00
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
108.50
52 WEEK LOW
57.00
MARKET CAP
68.87M
P/E (TTM)
-150.5082
1D
5D
1M
3M
1Y
5Y
Press Release: BIOQUAL Presents Unaudited Financial Results for Third Quarter of Fiscal Year 2024
BIOQUAL Presents Unaudited Financial Results for Third Quarter of Fiscal Year 2024. The company's results are forward-looking and subject to risks and uncertainties. BIOQUAL's revenue for the third quarter of fiscal year 2024 was $46.2 million. The Company's animal models are used in scientific research.
Dow Jones · 1d ago
Weekly Report: what happened at BIOQ last week (0415-0419)?
Weekly Report · 1d ago
Weekly Report: what happened at BIOQ last week (0408-0412)?
Weekly Report · 04/15 12:18
Weekly Report: what happened at BIOQ last week (0401-0405)?
Weekly Report · 04/08 12:23
Weekly Report: what happened at BIOQ last week (0325-0329)?
Weekly Report · 04/01 12:19
Weekly Report: what happened at BIOQ last week (0318-0322)?
Weekly Report · 03/25 12:23
Weekly Report: what happened at BIOQ last week (0311-0315)?
Weekly Report · 03/18 12:21
Weekly Report: what happened at BIOQ last week (0304-0308)?
Weekly Report · 03/11 12:16
More
About BIOQ
Bioqual, Inc. is a provider of research, development, consulting and testing/assay services to commercial clients and Government laboratories. The Company supports the National Institutes of Health by providing research services in the research areas of cancer, acquired immune deficiency syndrome (AIDS), hepatitis, influenza, immunology, transgenics, contraception, breeding and development of genetically defined animals, and neurobiology and behavior. The Company's research contracts consist of cancer virus studies, congenic animal development and monoclonal antibody research. The Company's research services include primate biology and medicine, small laboratory animal sciences, infectious disease research, in vitro laboratory services, environmental enrichment and behavior, good laboratory practice (GLP) studies, and partnerships for contracts and grants. The Company holds government contracts, which utilize the non-human primate model to study assorted human diseases.

Webull offers BIOQUAL, Inc. stock information, including OTCPK: BIOQ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIOQ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIOQ stock methods without spending real money on the virtual paper trading platform.